Not all leukemias are the same. Because every case is different, the treatment plan must be too. Each type of leukemia behaves differently—from slow-growing chronic forms to aggressive acute variants—successful treatment requires highly specialized care, advanced diagnostics, and a multidisciplinary medical team. At St. Luke’s Medical Center–Global City, patients diagnosed with leukemia are supported by the Blood Cancer Care Service, a specialized program that provides comprehensive, personalized treatment for blood cancers like leukemia, lymphoma, and multiple myeloma. 

Expertise Across All Types of Leukemia

St. Luke’s-Global City's Blood Cancer Care Service is composed of distinguished, subspecialized hematologists, medical oncologists, geneticists, and pathologists with extensive experience in diagnosing and treating both common and uncommon forms of leukemia. These include widely diagnosed types such as acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myelogenous leukemia (CML), as well as rare, uncommon, and complex leukemias such as myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and other genetically driven or atypical variants. This depth of expertise ensures that even the rarest cases receive precise diagnosis and highly specialized, evidence-based care.

Advanced Diagnostic and Testing Capabilities

Accurate diagnosis is the foundation of effective leukemia treatment. St. Luke’s- Global City employs advanced laboratory and molecular testing, including bone marrow examination, flow cytometry, cytogenetic analysis, and genetic and molecular profiling. These tests allow specialists to identify the exact leukemia subtype, assess disease aggressiveness, and determine how a patient is likely to respond to specific therapies—paving the way for more precise and personalized treatment plans.

Comprehensive and Personalized Treatment Options

Treatment for leukemia is tailored to each patient’s condition, overall health, and genetic profile. Available treatment modalities include chemotherapy, targeted therapy, immunotherapy, and stem cell transplantation. For eligible patients, the medical team coordinates advanced therapeutic approaches and long-term disease management, ensuring continuity of care from diagnosis through recovery and follow-up.

A multidisciplinary approach brings together hematologists, oncologists, nurses, pharmacists, and allied health professionals who work closely with patients and families, ensuring that medical, emotional, and supportive needs are addressed at every stage of the leukemia journey.

Trusted Patient-Centered Care

Beyond medical expertise, St. Luke’s is committed to compassionate, patient-centered care. Patients receive clear guidance, timely consultations, and access to support services designed to help them navigate diagnosis and treatment with confidence. The hospital’s long-standing reputation for healthcare excellence reflects its dedication to delivering the best clinical outcomes.

Take the First Step Toward Expert Care

Leukemia demands timely and precise attention—and subspecialized care can make a critical difference. If you or a loved one is experiencing symptoms, has abnormal blood test results, or has been diagnosed with leukemia, now is the time to seek expert consultation. Schedule a consultation and diagnostic testing at St. Luke’s Blood Cancer Care Service and place your care in the hands of leading leukemia specialists and highly-focused subspecialists equipped to manage even the rarest and most complex blood cancers. Early evaluation can open the door to targeted treatment and better outcomes—because when it comes to leukemia, expertise matters.

For inquiries, contact the Blood Cancer Care Service at St. Luke's Medical Center-Global City at (+632) 8789-7700 ext. 4801 or email cancerinstitute.bgc@stlukes.com.ph.

Learn more about the Blood Cancer Service